Other languages Arecor Therapeutics plc

Equities

AREC

GB00BMWLM973

Market Closed - London S.E. Other stock markets 11:35:04 2024-05-01 am EDT			5-day change	1st Jan Change
137.5 ^GBX	+0.73%		+3.77%	-24.66%

Apr. 23	Arecor chief financial officer to leave in July after five years	AN
Apr. 23	Arecor Therapeutics CFO to Leave in July	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Arecor chief financial officer to leave in July after five years	Apr. 23
Arecor Therapeutics plc Announces Stepping Down of Susan Lowther as Company Secretary and as A Board Director, Effective from July 22,2024	Apr. 23
Arecor to develop "holy grail" diabetes treatment with partner TRx	Mar. 12
Arecor Therapeutics plc and Trx Biosciences Limited Announces Research Collaboration for the Formulation Development of an Oral GLP-1 Receptor Agonist Product	Mar. 12
EARNINGS AND TRADING: East Star, Getech strike Kazakhstan JV	Feb. 29
Arecor Therapeutics hails Arestat as 2023 performance "strong"	Feb. 01
Arecor pleased as investee Inhibrx sells therapy to Sanofi	Jan. 23
Patent boosts for DG Innovate and Arecor Therapeutics	Jan. 18
Arecor expands speciality hospital collaboration with partner	Jan. 08
Arecor Therapeutics Expands Formulation Study Collaboration with Pharmaceutical Partner	Jan. 08
Arecor Therapeutics plc Expands Ongoing, Exclusive Formulation Study Collaboration with the Pharmaceutical Division of One of the World's Largest Chemicals Marketing and Pharmaceuticals Companies	Jan. 08
Arecor inks co-development deal with global medical company	Dec. 04
Arecor Therapeutics Signs Exclusive License Option Agreement for Oncology Product	Dec. 04
Arecor Therapeutics plc Announces Co-Development and Exclusive Licence Option Agreement	Dec. 04
Arecor inks Eli Lilly deal; RBG appoints McNair CFO	Nov. 29
Arecor Therapeutics plc Signs Further Collaboration Agreement with Lilly and Company	Nov. 29
Arecor Therapeutics gets "milestone payment" from AT220 sale	Nov. 17
Arecor Therapeutics to Receive Milestone Payment from Maiden Commercial Sale of Arestat Technology Product	Nov. 17
Troy Income suspends buyback of shares	Nov. 02
Arecor Therapeutics ups subject numbers for insulin-focused trial	23-10-02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Arecor Therapeutics plc

Equities

AREC

GB00BMWLM973

Other languages

Filters